Fund Holdings — Tri Locum Partners LP

Total Portfolio Value:
$813.22M
Total Bought:
$346.20M
Total Sold:
$246.89M
Net Transaction:
+$99.31M
Notable People:
Tri Locum Partners Gp Llc
Securities
▲▼
SharesValue
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Johnson & Johnson(JNJ)414,503424,945+10,442$101.32M$107.92M13.27%+$6.60M
Vertex Pharmaceuticals Incorporated(VRTX)129,314201,791+72,477$57.74M$100.24M12.33%+$42.49M
Eli Lilly and Company(LLY)61,79576,532+14,737$56.84M$91.79M11.29%+$34.96M
Ascendis Pharma A/S(ASND)0258,740+258,740$0$69.01M8.49%+$69.01M
DexCom, Inc.(DXCM)698,158820,479+122,321$43.84M$55.26M6.80%+$11.41M
Axsome Therapeutics, Inc.(AXSM)62,116219,308+157,192$10.50M$53.68M6.60%+$43.18M
Jazz Pharmaceuticals plc(JAZZ)158,663221,720+63,057$30.00M$53.43M6.57%+$23.43M
ENLIVEN THERAPEUTICS INC0866,716+866,716$0$43.99M5.41%+$43.99M
argenx SE(ARGX)31,63541,596+9,961$23.10M$38.59M4.75%+$15.49M
Madrigal Pharmaceuticals, Inc.(MDGL)103,28868,273-35,015$54.07M$36.66M4.51%-$17.41M
Revolution Medicines, Inc.(RVMD)0151,822+151,822$0$28.43M3.50%+$28.43M
United Therapeutics Corporation(UTHR)70,37047,026-23,344$41.73M$25.48M3.13%-$16.25M
Teva Pharmaceutical Industries Limited(TEVA)1,021,008746,835-274,173$30.75M$25.30M3.11%-$5.45M
Tarsus Pharmaceuticals, Inc.(TARS)252,588328,340+75,752$17.72M$20.67M2.54%+$2.95M
INTUITIVE SURGICAL INC153,25047,983-105,267$70.65M$19.08M2.35%-$51.56M
Cytokinetics, Incorporated(CYTK)0194,000+194,000$0$16.53M2.03%+$16.53M
Dianthus Therapeutics, Inc.(DNTH)145,543120,712-24,831$12.21M$11.77M1.45%-$447.0K
Beta Bionics, Inc.(BBNX)0493,344+493,344$0$7.73M0.95%+$7.73M
Definium Therapeutics, Inc.(DFTX)369,588162,996-206,592$6.99M$7.67M0.94%+$682.1K
Ascendis Pharma A/S(ASND)255,3320-255,332$58.40M$0—-$58.40M
NUVALENT INC308,5060-308,506$31.61M$0—-$31.61M
Thermo Fisher Scientific Inc.(TMO)132,4130-132,413$65.08M$0—-$65.08M
Page 1 of 1
Tri Locum Partners LP — 13F Holdings — Q2 2026 | TickerTrail